FOXN3 Inhibits Cell Proliferation though Regulating E2F1 in Prostate Cancer

被引:0
作者
Zhang, Ning [1 ]
Yang, Haijun [1 ]
Zeng, Qingqi [1 ]
机构
[1] Jiangsu Hlth Vocat Coll, Dept Tradit Chinese Med, 69 Huangshanling Rd, Nanjing 211800, Jiangsu, Peoples R China
关键词
Prostate cancer; FOXN3; E2F1; cell proliferation;
D O I
10.36468/pharmaceutical-sciences.spl.113
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study, it was demonstrated that forkhead box N3 was downregulated in prostate cancer tissues compared to the matched normal adjacent tissues. Prostate cancer patients with high forkhead box N3 expression more frequently had longer survival (P<0.05) than those with low forkhead box N3 expression. Forkhead box N3 inhibited prostate cancer cell proliferation in vitro and in vivo. In addition, forkhead box N3 repressed expression of E2F1, a reported potential oncogene at the messenger ribonucleic acid and protein levels. Taken together, these data delineate an unrecognized function of forkhead box N3 as a tumor suppressor in prostate cancer via repressing the expression of E2F1.
引用
收藏
页码:137 / 143
页数:7
相关论文
共 26 条
[1]   E2F1 in Melanoma Progression and Metastasis [J].
Alla, Vijay ;
Engelmann, David ;
Niemetz, Annett ;
Pahnke, Jens ;
Schmidt, Anke ;
Kunz, Manfred ;
Emmrich, Stephan ;
Steder, Marc ;
Koczan, Dirk ;
Puetzer, Brigitte M. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (02) :127-133
[2]   Prostate cancer: diagnosis and staging [J].
Borley, Nigel ;
Feneley, Mark R. .
ASIAN JOURNAL OF ANDROLOGY, 2009, 11 (01) :74-80
[3]   Multiple endocrine neoplasia type 1 interacts with forkhead transcription factor CHES1 in DNA damage response [J].
Busygina, Valeria ;
Kottermann, Mohy C. ;
Scott, Kenneth L. ;
Plon, Sharon E. ;
Bale, Allen E. .
CANCER RESEARCH, 2006, 66 (17) :8397-8403
[4]   miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer [J].
Cai, Chao ;
Chen, Qing-Biao ;
Han, Zhao-Dong ;
Zhang, Yan-Qiong ;
He, Hui-Chan ;
Chen, Jia-Hong ;
Chen, Yan-Ru ;
Yang, Sheng-Bang ;
Wu, Yong-Ding ;
Zeng, Yan-Ru ;
Qin, Guo-Qiang ;
Liang, Yu-Xiang ;
Dai, Qi-Shan ;
Jiang, Fu-Neng ;
Wu, Shu-lin ;
Zeng, Guo-Hua ;
Zhong, Wei-De ;
Wu, Chin-Lee .
CLINICAL CANCER RESEARCH, 2015, 21 (21) :4922-4934
[5]   International Variation in Prostate Cancer Incidence and Mortality Rates [J].
Center, Melissa M. ;
Jemal, Ahmedin ;
Lortet-Tieulent, Joannie ;
Ward, Elizabeth ;
Ferlay, Jacques ;
Brawley, Otis ;
Bray, Freddie .
EUROPEAN UROLOGY, 2012, 61 (06) :1079-1092
[6]   Identification of differentially expressed genes in oral squamous cell carcinoma (OSCC): Overexpression of NPM, CDK1 and NDRG1 and underexpression of CHES1 [J].
Chang, JT ;
Wang, HM ;
Chang, KW ;
Chen, WH ;
Wen, MC ;
Hsu, YM ;
Yung, BYM ;
Chen, IH ;
Liao, CT ;
Hsieh, LL ;
Cheng, AJ .
INTERNATIONAL JOURNAL OF CANCER, 2005, 114 (06) :942-949
[7]   Pocket proteins and cell cycle control [J].
Cobrinik, D .
ONCOGENE, 2005, 24 (17) :2796-2809
[8]   Loss of FOXN3 in colon cancer activates beta-catenin/TCF signaling and promotes the growth and migration of cancer cells [J].
Dai, Yuedi ;
Wang, Meixing ;
Wu, Haixia ;
Xiao, Mi ;
Liu, Houbao ;
Zhang, Dexiang .
ONCOTARGET, 2017, 8 (06) :9783-9793
[9]   Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance [J].
Engelmann, David ;
Puetzer, Brigitte M. .
DRUG RESISTANCE UPDATES, 2010, 13 (4-5) :119-131
[10]   Balancing the decision of cell proliferation and cell fate [J].
Hallstrom, Timothy C. ;
Nevins, Joseph R. .
CELL CYCLE, 2009, 8 (04) :532-535